RTW Biotech Opportunities Ltd RTWFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -70.60% | -70.60% | -9.99% | -9.99% | 936.90% |
| Total Revenue | -70.60% | -70.60% | -9.99% | -9.99% | 936.90% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -70.60% | -70.60% | -9.99% | -9.99% | 936.90% |
| SG&A Expenses | 12.76% | 12.76% | -2.47% | -2.47% | 19.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.78% | 12.78% | 3.24% | 3.24% | 23.88% |
| Operating Income | -95.36% | -95.36% | -55.82% | -55.82% | 972.22% |
| Income Before Tax | 515.40% | 515.40% | 653.64% | 653.64% | -147.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 515.40% | 515.40% | 653.64% | 653.64% | -147.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 515.40% | 515.40% | 653.64% | 653.64% | -147.46% |
| EBIT | -95.36% | -95.36% | -55.82% | -55.82% | 972.22% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 525.28% | 525.28% | 669.57% | 669.57% | -148.28% |
| Normalized Basic EPS | -55.97% | -55.97% | 377.27% | 377.27% | -77.59% |
| EPS Diluted | 525.28% | 525.28% | 669.57% | 669.57% | -148.28% |
| Normalized Diluted EPS | -55.97% | -55.97% | 377.27% | 377.27% | -77.59% |
| Average Basic Shares Outstanding | -2.32% | -2.32% | -2.78% | -2.78% | -1.68% |
| Average Diluted Shares Outstanding | -2.32% | -2.32% | -2.78% | -2.78% | -1.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |